GenTrust’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.06M Sell
885
-67
-7% -$68.5K 0.04% 106
2026
Q1
$875K Buy
952
+175
+23% +$177K 0.04% 120
2025
Q4
$835K Buy
777
+29
+4% +$27.7K 0.04% 125
2025
Q3
$571K Sell
748
-34
-4% -$25.3K 0.03% 134
2025
Q2
$610K Sell
782
-95
-11% -$73.8K 0.03% 117
2025
Q1
$724K Buy
877
+16
+2% +$13.3K 0.03% 110
2024
Q4
$665K Buy
861
+9
+1% +$7.45K 0.03% 122
2024
Q3
$755K Buy
852
+177
+26% +$159K 0.04% 120
2024
Q2
$611K Hold
675
0.03% 110
2024
Q1
$525K Buy
675
+290
+75% +$206K 0.03% 97
2023
Q4
$224K Hold
385
0.01% 121
2023
Q3
$207K Buy
+385
New +$198K 0.01% 129

Other funds holding LLY

GenTrust's LLY Position: Q2 2026 in Review

GenTrust reduced its Eli Lilly (LLY) stake by 7% in Q2 2026, selling an estimated $68.5K and leaving 885 shares worth $1.06M. The position accounts for 0.04% of the portfolio, ranked #106.

GenTrust first reported a position in LLY in Q3 2023 and has held it in 12 quarters since. 4,623 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • GenTrust held 885 shares of Eli Lilly worth $1.06M as of Q2 2026.
  • GenTrust sold 67 Eli Lilly shares in Q2 2026, an estimated $68.5K.
  • Eli Lilly made up 0.04% of GenTrust's portfolio in Q2 2026, its #106 holding.
  • GenTrust first reported a position in Eli Lilly in Q3 2023 and has held it in 12 quarters since.
  • 4,623 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on GenTrust's 13F filing for Q2 2026, filed 6 Aug 2026.